SOF+DCV

DRUG2 trials

Sponsors

Humanity and Health Research Centre, Tanta University

Conditions

Chronic Hepatitis C InfectionHCV Infection ( Genotype 4) in CKD Patients

Phase 2

Treatment of CKD Patients With HCV

Not yet recruitingNCT07770984

Tanta UniversityHCV Infection ( Genotype 4) in CKD Patients

Start: 2026-09-15End: 2027-05-15Target: 50Updated: 2026-08-20

Phase 4

Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT2 Infected Patients

CompletedNCT02482077

Humanity and Health Research CentreChronic Hepatitis C Infection

Start: 2015-01-31End: 2018-03-15Updated: 2018-03-19